AU2291899A - Fast dissolving pharmaceutical products - Google Patents

Fast dissolving pharmaceutical products

Info

Publication number
AU2291899A
AU2291899A AU22918/99A AU2291899A AU2291899A AU 2291899 A AU2291899 A AU 2291899A AU 22918/99 A AU22918/99 A AU 22918/99A AU 2291899 A AU2291899 A AU 2291899A AU 2291899 A AU2291899 A AU 2291899A
Authority
AU
Australia
Prior art keywords
pharmaceutical products
fast dissolving
dissolving pharmaceutical
fast
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22918/99A
Inventor
Harry Seagar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Pharma Solutions Inc
Original Assignee
Catalent Pharma Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Pharma Solutions Inc filed Critical Catalent Pharma Solutions Inc
Publication of AU2291899A publication Critical patent/AU2291899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
AU22918/99A 1998-01-30 1999-01-29 Fast dissolving pharmaceutical products Abandoned AU2291899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9802088 1998-01-30
GBGB9802088.6A GB9802088D0 (en) 1998-01-30 1998-01-30 Pharmaceutical products
PCT/GB1999/000317 WO1999038496A1 (en) 1998-01-30 1999-01-29 Fast dissolving pharmaceutical products

Publications (1)

Publication Number Publication Date
AU2291899A true AU2291899A (en) 1999-08-16

Family

ID=10826221

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22918/99A Abandoned AU2291899A (en) 1998-01-30 1999-01-29 Fast dissolving pharmaceutical products

Country Status (3)

Country Link
AU (1) AU2291899A (en)
GB (1) GB9802088D0 (en)
WO (1) WO1999038496A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (en) 2000-05-30 2001-12-06 Basf Ag Self-emulsifying active ingredient formulation and use of this formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US7700608B2 (en) 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
EP2200613B1 (en) 2007-09-21 2018-09-05 The Johns Hopkins University Phenazine derivatives and uses thereof
US9775819B2 (en) 2009-09-16 2017-10-03 R.P. Scherer Technologies, Llc Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
PL2493457T3 (en) 2009-10-30 2018-01-31 Ix Biopharma Ltd Fast dissolving solid dosage form
KR20240031326A (en) 2016-12-31 2024-03-07 바이오엑셀 테라퓨틱스 인코포레이티드 Use of Sublingual Dexmedetomidine for the treatment of Agitation
CA3103431A1 (en) 2018-06-27 2020-01-02 Bioxcel Therapeutics, Inc. Film formulations containing dexmedetomidine and methods of producing them
CA3145388A1 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
FR2634376B1 (en) * 1988-07-21 1992-04-17 Farmalyoc NOVEL SOLID AND POROUS UNIT FORM COMPRISING MICROPARTICLES AND / OR NANOPARTICLES, AS WELL AS ITS PREPARATION
US5073374A (en) * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
US5714167A (en) * 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5693338A (en) * 1994-09-29 1997-12-02 Emisphere Technologies, Inc. Diketopiperazine-based delivery systems
JP2807346B2 (en) * 1991-12-24 1998-10-08 山之内製薬株式会社 Orally disintegrating preparation and production method thereof
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
US5401516A (en) * 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
US5569448A (en) * 1995-01-24 1996-10-29 Nano Systems L.L.C. Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
US5565188A (en) * 1995-02-24 1996-10-15 Nanosystems L.L.C. Polyalkylene block copolymers as surface modifiers for nanoparticles
GEP20012374B (en) * 1995-03-02 2001-03-25 Scherer Ltd R P Pharmaceutical Compositions Comprising Monoamine Oxidase B Inhibitors, Method for Obtaining the Same and Use
US5820881A (en) * 1995-04-28 1998-10-13 Emisphere Technologies, Inc. Microspheres of diamide-dicarboxylic acids
GB9616672D0 (en) * 1996-08-08 1996-09-25 Scherer Ltd R P Pharmaceutical compositions

Also Published As

Publication number Publication date
GB9802088D0 (en) 1998-03-25
WO1999038496A1 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU1071301A (en) Pharmaceutical compounds
AU3733399A (en) Drug composites
AU5259100A (en) Medicament
AU6356799A (en) Tablet package
GB9801538D0 (en) Pharmaceutical product
AU4328800A (en) Pharmaceutical formulation
AU1409100A (en) Drugs
AU2291899A (en) Fast dissolving pharmaceutical products
AU6263400A (en) Polyisocyanate-polyaddition products
AU6460400A (en) Pharmaceutical compositions
AU1645700A (en) Oenothein medicaments
AU2692200A (en) Enteral sorbefacients
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
AU2991200A (en) Antiangiogenic drugs
AU5722900A (en) Pharmaceutical compounds
AU6460200A (en) Pharmaceutical compositions
AU6480299A (en) Pharmaceutical compounds
AUPP332898A0 (en) Pharmaceutical composition
AU2001274535A1 (en) Hydroxyformamidine derivatives and medicines containing the same
AU1688099A (en) Pharmaceutical preparation
AU3839900A (en) Pharmaceutical formulation
AU6460300A (en) Pharmaceutical compositions
AU6460100A (en) Pharmaceutical compositions
AU5182099A (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase